A cholecystokinin receptor antagonist inhibits the osteoarthritis features induced by GPR22 in vitro and in vivo. (April 2018) - Guns, L.; Monteagudo, S.; Calebiro, D.; Lohse, M.; Lories, R.; Cailotto, F.